China NT Pharma Group Company Limited (HKG:1011)

HKG:1011 Revenue

China NT Pharma Group Company had revenue of 23.67M CNY in the half year ending June 30, 2026, a decrease of -24.39%. This brings the company's total for the last twelve months to 35.83M, up 92.02% year-over-year. In the year 2025, China NT Pharma Group Company had annual revenue of 24.16M, down -36.36%. That makes China NT Pharma Group Company the 39,774th largest company in the world by revenue and 2,432nd in Hong Kong.

• Revenue (ttm): 35.83M CNY
• Revenue Growth: +92.02%
• P/S Ratio: 7.23
• Revenue / Employee: 1.12M CNY
• Employees: 32
• Market Cap: 270.46M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Healthcare Related Services 14.53M 60.1%
• Agency Services 9.63M 39.9%

By Geography

Chart

• Chinese Mainland 23.47M 97.2%
• Hong Kong 685.00K 2.8%

Fiscal year ended Dec 31, 2025 See the full HKG:1011 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	24.16M	-13.80M	-36.36%
Dec 31, 2024	37.96M	30.59M	415.34%
Dec 31, 2023	7.37M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	226.70M	4.97M	2.24%

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error